Ajax-Loading

Amgen Inc - Accounts Payable

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accounts-Payable" stands at 2.84 Billion United States Dollars as of 09/30/2025.

As of the end of Amgen Inc's third quarter, the item "Accounts Payable" stands at 2.84 Billion USD. This represents a decrease of -5.71 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 32.18 percent compared to the value the year prior.
The 1 year change in percent is 32.18.
The 3 year change in percent is 135.71.
The 5 year change in percent is 144.44.
The 10 year change in percent is 165.98.

The Serie's long term average value is 1.21 Billion United States Dollars. It's latest available value, on 09/30/2025, is 135.22 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +342.06%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -5.71%.

Accounts Payable for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Accounts Payable905,699,262,464.00
LogoJohnson & Johnson - Accounts Payable486,508,953,600.00
LogoAbbVie Inc - Accounts Payable399,570,305,024.00
LogoRoche Holding AG - Accounts Payable317,433,206,677.55
LogoAstraZeneca PLC - Accounts Payable280,205,508,085.11